3rd Circuit Remands 507 Fosamax Femur Injury Cases For Judge’s Preemption Ruling

(December 2, 2019, 1:45 PM EST) -- PHILADELPHIA — Following the U.S. Supreme Court’s May 20 preemption ruling, a panel of the Third Circuit U.S. Court of Appeals on Nov. 25 remanded 507 Fosamax femur fracture cases to a multidistrict litigation court in New Jersey for determination of whether the plaintiff’s claims are preempted (In Re:  Fosamax [Alendronate Sodium] Product Liability Litigation, No. 14-2813, 3rd Cir.)....

Attached Documents

Related Sections